WW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WW is not a good buy right now for an impatient investor. The chart is in a clear downtrend (bearish MA stack, negative MACD), price is breaking below near-term support (~20.38), and the next-day/week/month pattern stats also skew negative. While RSI is extremely oversold (bounce risk), there is no Intellectia buy signal to prioritize, and the fundamental/news backdrop remains unfavorable. I would avoid buying here and only reconsider after a base forms back above ~20.38–22.20.
Trend: Bearish. SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum: MACD histogram -0.632 (below zero) and still negative, suggesting downside momentum remains despite some contraction. Overbought/oversold: RSI_6 = 15.75 (extremely oversold) → a short-term bounce is possible, but oversold can persist in strong downtrends. Levels: Price 20.21 is below S1 20.378 (lost support). Next support S2 ~19.252. Resistance/pivot overhead at 22.201, then 24.024. Probabilistic near-term bias (pattern analogs): ~70% chance of further drift lower (-0.61% next day, -1.55% next week, -2.8% next month).
Intellectia Proprietary Trading Signals
on 2026-03-02 pre-market could act as a catalyst if results or guidance surprise to the upside.
with bearish moving averages and negative MACD.
Latest quarter: 2025/Q3. Revenue fell to $172.091M (-10.78% YoY), indicating ongoing top-line contraction. Profitability: Net income is still a loss (-$57.516M) but improved YoY (+24.52%). EPS improved sharply YoY to -5.76 (still deeply negative). Margins: Gross margin improved to 72.11% (+4.33% YoY), a positive efficiency signal, but it has not translated into profitability yet—overall growth trend remains weak due to declining revenue.
Recent change: Morgan Stanley (2025-11-07) lowered PT to $38 from $41 and maintained Equal Weight. Street pros/cons framing: Pros—large PT above current price implies perceived upside if execution stabilizes; margin improvement suggests cost discipline. Cons—PT cut signals reduced confidence; Equal Weight is not a high-conviction buy; revenue contraction and structural GLP-1 competition keep fundamental risk elevated. Influential trading: Hedge funds and insiders are neutral; no recent congress trading data available.
